GREM1 and neoplasm: GREM1, primarily expressed by stromal cells (Sneddon et al., 2006), is a bone morphogenetic protein (BMP) antagonist implicated in tumor progression (Minsoo Kim et al., 2012b) and EMT (Karagiannis et al., 2015).